-
1
-
-
50349104499
-
Mycophenolic acid: An antibiotic from Penicillium brevicompactum Dierckx
-
Florey HW, Gilliver K, Jennings MA, Sanders AG. Mycophenolic acid: an antibiotic from Penicillium brevicompactum Dierckx. Lancet 1946; i: 46.
-
(1946)
Lancet
, vol.1
, pp. 46
-
-
Florey, H.W.1
Gilliver, K.2
Jennings, M.A.3
Sanders, A.G.4
-
2
-
-
0029115531
-
Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients: US Renal Transplant Mycophenolate Mofetil Study Group
-
Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients: US Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 1995; 60: 625.
-
(1995)
Transplantation
, vol.60
, pp. 625
-
-
Sollinger, H.W.1
-
3
-
-
0029006409
-
Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection
-
European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 1995; 345: 1321.
-
(1995)
Lancet
, vol.345
, pp. 1321
-
-
-
4
-
-
0006986048
-
A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation
-
The Tricontinental Mycophenolate mofetil Renal Transplantation Study Group. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. Transplantation 1996; 61: 1029.
-
(1996)
Transplantation
, vol.61
, pp. 1029
-
-
-
5
-
-
0031024728
-
Mycophenolate mofetil in renal allograft recipients: A pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection
-
Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. Transplantation 1997; 63: 39.
-
(1997)
Transplantation
, vol.63
, pp. 39
-
-
Halloran, P.1
Mathew, T.2
Tomlanovich, S.3
Groth, C.4
Hooftman, L.5
Barker, C.6
-
6
-
-
0032570276
-
Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients
-
Roth D, Colona J, Burke GW, Ciancio G, Esquenazi V, Miller J. Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients. Transplantation 1998; 65: 248.
-
(1998)
Transplantation
, vol.65
, pp. 248
-
-
Roth, D.1
Colona, J.2
Burke, G.W.3
Ciancio, G.4
Esquenazi, V.5
Miller, J.6
-
7
-
-
0032570304
-
Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation
-
Eckhoff DE, McGuire BM, Frenette LR, Contreras JL, Hudson SL, Bynon JS. Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation. Transplantation 1998; 65: 180.
-
(1998)
Transplantation
, vol.65
, pp. 180
-
-
Eckhoff, D.E.1
McGuire, B.M.2
Frenette, L.R.3
Contreras, J.L.4
Hudson, S.L.5
Bynon, J.S.6
-
8
-
-
0025281073
-
Bioavailability improvement of mycophenolic acid through amino ester derivatization
-
Lee WA, Gu L, Miksztal AR, Chu N, Leung K, Nelson PH. Bioavailability improvement of mycophenolic acid through amino ester derivatization. Pharmacol Res 1990; 7: 161.
-
(1990)
Pharmacol Res
, vol.7
, pp. 161
-
-
Lee, W.A.1
Gu, L.2
Miksztal, A.R.3
Chu, N.4
Leung, K.5
Nelson, P.H.6
-
9
-
-
0027218826
-
Immunosuppressive activity of mycophenolate mofetil
-
Eugui EM, Allison AC. Immunosuppressive activity of mycophenolate mofetil. Ann NY Acad Sci 1993; 685: 309.
-
(1993)
Ann NY Acad Sci
, vol.685
, pp. 309
-
-
Eugui, E.M.1
Allison, A.C.2
-
10
-
-
0029918886
-
Purine metabolism and immunosuppressive effects of mycophenolate mofetil
-
Allison AC, Eugui EM. Purine metabolism and immunosuppressive effects of mycophenolate mofetil. Clin Transplant 1996; 10: 77.
-
(1996)
Clin Transplant
, vol.10
, pp. 77
-
-
Allison, A.C.1
Eugui, E.M.2
-
11
-
-
0027996920
-
Infectious complications in liver transplant recipients on tacrolimus
-
Singh N, Gayowski T, Wagener M, Yu VL. Infectious complications in liver transplant recipients on tacrolimus. Transplantation 1994; 58: 774.
-
(1994)
Transplantation
, vol.58
, pp. 774
-
-
Singh, N.1
Gayowski, T.2
Wagener, M.3
Yu, V.L.4
-
12
-
-
12644290296
-
Mycophenolate mofetil rescue therapy in liver transplant recipients
-
Gavlik A, Goldberg MG, Tsaroucha A, et al. Mycophenolate mofetil rescue therapy in liver transplant recipients. Transplant Proc 1997; 29: 549.
-
(1997)
Transplant Proc
, vol.29
, pp. 549
-
-
Gavlik, A.1
Goldberg, M.G.2
Tsaroucha, A.3
-
13
-
-
0030773555
-
Mycophenolate mofetil rescue therapy in liver transplant recipients: An extended follow-up
-
Gavlik A, Demirbas A, Tsaroucha A, et al. Mycophenolate mofetil rescue therapy in liver transplant recipients: an extended follow-up. Transplant Proc 1997; 29: 2971.
-
(1997)
Transplant Proc
, vol.29
, pp. 2971
-
-
Gavlik, A.1
Demirbas, A.2
Tsaroucha, A.3
-
14
-
-
0023821657
-
CDC definitions for nosocomial infections
-
Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128.
-
(1988)
Am J Infect Control
, vol.16
, pp. 128
-
-
Garner, J.S.1
Jarvis, W.R.2
Emori, T.G.3
Horan, T.C.4
Hughes, J.M.5
-
15
-
-
0027996920
-
Infectious complications in liver transplant recipients on tacrolimus
-
Singh N, Gayowski T, Wagener MM, Yu VL. Infectious complications in liver transplant recipients on tacrolimus. Transplantation 1994; 58: 774.
-
(1994)
Transplantation
, vol.58
, pp. 774
-
-
Singh, N.1
Gayowski, T.2
Wagener, M.M.3
Yu, V.L.4
-
16
-
-
0026593734
-
Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia
-
Gerna G, Revello MG, Percivalle E, et al. Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. J Clin Microbiol 1992; 30: 1232.
-
(1992)
J Clin Microbiol
, vol.30
, pp. 1232
-
-
Gerna, G.1
Revello, M.G.2
Percivalle, E.3
-
17
-
-
0027979240
-
High-dose acyclovir compared to short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients: A randomized trial
-
Singh N, Yu VL, Mieles L, Wagener MM, Miner RC, Gayowski T. High-dose acyclovir compared to short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients: a randomized trial. Ann Intern Med 1994; 120: 375.
-
(1994)
Ann Intern Med
, vol.120
, pp. 375
-
-
Singh, N.1
Yu, V.L.2
Mieles, L.3
Wagener, M.M.4
Miner, R.C.5
Gayowski, T.6
-
18
-
-
0030066247
-
Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis
-
Singh N, Gayowski T, Wagener MM, Marino IR. Increased infections in liver transplant recipients with recurrent hepatitis C virus hepatitis. Transplantation 1996; 61: 402.
-
(1996)
Transplantation
, vol.61
, pp. 402
-
-
Singh, N.1
Gayowski, T.2
Wagener, M.M.3
Marino, I.R.4
-
19
-
-
0025726332
-
Recurrence of hepatitis C virus infection after orthotopic liver transplantation
-
Martin P, Munoz SJ, DiBisceglie AM, et al. Recurrence of hepatitis C virus infection after orthotopic liver transplantation. Hepatology 1991; 13: 719.
-
(1991)
Hepatology
, vol.13
, pp. 719
-
-
Martin, P.1
Munoz, S.J.2
DiBisceglie, A.M.3
-
20
-
-
0025819225
-
Hepatitis C in patients undergoing liver transplantation
-
Read AE, Donegan E, Lake JR, et al. Hepatitis C in patients undergoing liver transplantation. Ann Intern Med 1991; 114: 282.
-
(1991)
Ann Intern Med
, vol.114
, pp. 282
-
-
Read, A.E.1
Donegan, E.2
Lake, J.R.3
-
21
-
-
0019813866
-
Formulation and application of a numerical scoring system for assessing histologic activity in asymptomatic chronic active hepatitis
-
Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histologic activity in asymptomatic chronic active hepatitis. Hepatology 1981; 5: 431.
-
(1981)
Hepatology
, vol.5
, pp. 431
-
-
Knodell, R.G.1
Ishak, K.G.2
Black, W.C.3
-
22
-
-
0031463441
-
Prednisone withdrawal 14 days after liver transplantation with mycophnolate
-
Stegall MD, Wachs ME, Everson G, et al. Prednisone withdrawal 14 days after liver transplantation with mycophnolate. Transplantation 1997; 64: 1755.
-
(1997)
Transplantation
, vol.64
, pp. 1755
-
-
Stegall, M.D.1
Wachs, M.E.2
Everson, G.3
-
23
-
-
0031952851
-
The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo
-
Neyts J, Andrei G, De Clercq E. The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in vitro and in vivo. Antimicrob Agents Chemother 1998; 42: 216.
-
(1998)
Antimicrob Agents Chemother
, vol.42
, pp. 216
-
-
Neyts, J.1
Andrei, G.2
De Clercq, E.3
-
24
-
-
0030006172
-
Serum hepatitis C RNA titers after liver transplantation are not correlated with immunosuppression or hepatitis
-
Freeman RB, Tran S, Lee YM, Rohrer RJ, Kaplan MM. Serum hepatitis C RNA titers after liver transplantation are not correlated with immunosuppression or hepatitis. Transplantation 1996; 61: 542.
-
(1996)
Transplantation
, vol.61
, pp. 542
-
-
Freeman, R.B.1
Tran, S.2
Lee, Y.M.3
Rohrer, R.J.4
Kaplan, M.M.5
-
25
-
-
0031028176
-
The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein
-
Odom A, Del Poeta M, Perfect J, Heitman J. The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. Antimicrob Agents Chemother 1997; 41: 156.
-
(1997)
Antimicrob Agents Chemother
, vol.41
, pp. 156
-
-
Odom, A.1
Del Poeta, M.2
Perfect, J.3
Heitman, J.4
-
26
-
-
0030944969
-
Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus and dexamethasone
-
Oz HS, Hughes WT. Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus and dexamethasone. J Infect Dis 1997; 175: 901.
-
(1997)
J Infect Dis
, vol.175
, pp. 901
-
-
Oz, H.S.1
Hughes, W.T.2
-
27
-
-
0029922910
-
Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplantation rejection
-
Danovitch G, Deierhoi M, Ferguson R, et al. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplantation rejection. Transplantation 1996; 61: 722.
-
(1996)
Transplantation
, vol.61
, pp. 722
-
-
Danovitch, G.1
Deierhoi, M.2
Ferguson, R.3
|